Journal
EXPERT REVIEW OF RESPIRATORY MEDICINE
Volume 8, Issue 1, Pages 67-78Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1586/17476348.2014.852471
Keywords
immunodiagnosis; interferon-gamma release assays; latent infection; mycobacteria; national guidelines; tuberculin skin test; tuberculosis
Categories
Funding
- National Institute for Health Research [NF-SI-0508-10179, ACF-2006-21-016] Funding Source: researchfish
- Department of Health [08/106/02] Funding Source: Medline
Ask authors/readers for more resources
Interferon-gamma release assays (IGRAs) represent the first new tool to diagnose latent tuberculosis infection for more than 100 years. They have advantages over the traditional tuberculin skin test which has a poor specificity due to false-positive responses in people who are BCG vaccinated as there is a cross-reactivity of proteins present in both BCG and the tuberculin skin test. IGRAs rely on the concept of detecting the ex vivo release of the cytokine IFN-gamma, a key anti-Mycobacterium tuberculosis cytokine, from T cells which react specifically to antigens from M. tuberculosis. T cells are sensitized to the antigens in vivo, and then react when they encounter the same proteins ex vivo. The readouts are used to determine presence of sensitized cells, acting as a surrogate for latent tuberculosis infection. IGRAs are now being incorporated into national guidance for diagnosis and research is ongoing into next-generation versions of the test.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available